Hodgkin Lymphoma  >>  docetaxel  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
docetaxel / Generic mfg.
NCT05714553: NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Recruiting
1/2
91
Europe
Fosifloxuridine Nafalbenamide, NUC-3373, Nucleotide analogue, Leucovorin, Folinic acid, Levo-leucovorin, Pembrolizumab, Keytruda, Docetaxel, Taxotere, Docecad, Docefrez
NuCana plc
Advanced Cancer, Advanced Solid Tumor, Neoplasm Malignant, Metastatic Cancer, Melanoma, Classical Hodgkin Lymphoma, Non Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Carcinoma, Head and Neck Squamous Cell Carcinoma, Subungual Squamous Cell Carcinoma, Oesophageal Carcinoma, MSI-H Colorectal Cancer, Gastric Cancer, Triple Negative Breast Cancer, Endometrial Carcinoma, Pleural Mesothelioma
08/24
01/25

Download Options